Leman Biotech is a clinical-stage biotech company focusing on developing innovative cancer immunotherapies using our unique metabolic reprogramming technology
Leman Biotech is pleased to announce the successful treatment of the first patient with recurrent or refractory diffuse large B-cell lymphoma using our metabolically enhanced CD19 CAR-T therapy, Meta...